Quang X. Pham - 23 Jan 2025 SCHEDULE 13D Report for Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share (CVKD)

Filing Manager: Quang X. Pham
Reporting Manager: Quang X. Pham
Security: Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: CVKD
Shares outstanding: 1,784,076 shares
Disclosed Ownership: 421,042 shares
Ownership: 24%
Form type: SCHEDULE 13D
Filing time: 29 Jan 2025, 19:29:10 UTC
Date of event: 23 Jan 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Quang X. Pham	24%	421,042	221,042	200,000	/s/ Quang X. Pham	Quang X. Pham	0001405290
The PVBQ Living Trust	11%	200,000	0	200,000	/s/ Quang X. Pham	Quang X. Pham, Trustee	0001947432